# NEKTAR THERAPEUTICS (NKTR) FY2026 YTD Q2 Statement of Cash Flows

- Company: NEKTAR THERAPEUTICS (NKTR)
- Period: 2026-01-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-14, accession number 0001193125-26-349805
- Page: https://plicit.ai/financials/nktr/fy2026-ytd-q2-cash-flow
- Chart image: https://plicit.ai/charts/nktr-fy2026-ytd-q2-cash-flow-sankey.png

## Chart details

Cash flows for Jan 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 31, 2025. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

- **Beginning cash on Dec 31, 2025**: 15,116,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
- **Operating activities**: negative 120,068,000 US dollars. Net cash used.
- **Operating leases, net**: negative 6,835,000 US dollars
- **Non-cash royalty revenue related to the sales of future royalties**: negative 20,992,000 US dollars
- **Non-cash interest expense on liabilities related to the sales of future royalties**: 15,148,000 US dollars
- **Other assets**: negative 39,884,000 US dollars
- **Loss from equity method investment**: 2,069,000 US dollars
- **Depreciation and amortization expense**: 307,000 US dollars
- **Net loss**: negative 85,526,000 US dollars
- **Stock-based compensation**: 6,720,000 US dollars
- **Accounts payable**: 14,121,000 US dollars
- **Accrued expenses**: 37,000 US dollars
- **Amortization of premiums (discounts), net**: negative 5,233,000 US dollars
- **Investing activities**: negative 749,899,000 US dollars. Net cash used.
- **Purchases of investments**: negative 987,707,000 US dollars
- **Maturities of investments**: 237,920,000 US dollars
- **Payment of transaction costs and working capital adjustment from the sale of the Huntsville manufacturing facility**: 0 US dollars
- **Purchases of property and equipment**: negative 112,000 US dollars
- **Financing activities**: 894,118,000 US dollars. Net cash provided.
- **Proceeds from shares issued under equity compensation plans**: 4,933,000 US dollars
- **Payments of offering costs associated with issuance of common stock and pre-funded warrants**: negative 1,239,000 US dollars
- **Proceeds from offering, net - At-the-Market Offering**: 106,699,000 US dollars
- **Proceeds from offering, net - Underwritten Offering**: 783,725,000 US dollars
- **Operating adjustment reconciliation**: 158,470,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
- **financing gross reconciliation**: 895,357,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- **investing gross reconciliation**: 987,819,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- **Exchange-rate effect**: 0 US dollars
- **Ending cash on Jun 30, 2026**: 39,267,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
- **Cash sources and uses**: 909,234,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
- **Net cash change**: 24,151,000 US dollars. Ending cash minus beginning cash.
- **Cash flow / Net income**: Not meaningful. Operating cash flow divided by reconciliation net income for the same period. The ratio is not meaningful when net income is zero or negative.
- **Operating cash flow**: negative 120,068,000 US dollars. Operating cash flow used in the free cash flow calculation.
- **Cash purchases of property, plant and equipment**: 112,000 US dollars. These cash purchases are already included in investing activities above.
- **Free cash flow**: negative 120,180,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

### Chart connections

- Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
- Financing contributions meet at a reconciliation junction before connecting to the net cash total.
- Investing contributions meet at a reconciliation junction before connecting to the net cash total.
- Operating reconciliation adjustments are not all independent cash receipts.
- Net loss −$85.53M − net operating adjustments $34.54M = operating cash −$120.07M. The loss reduces the earnings basis of the reconciliation; it is not a cash payment. The signed loss remains a deduction at the operating reconciliation junction.
- Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
- The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
- Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: negative 120,068,000 US dollars minus 112,000 US dollars equals negative 120,180,000 US dollars.